HCP engagement

Reshaping events in pharma

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. With medical conferences and events long a mainstay for pharma-HCP interactions, the pandemic’s travel restrictions, and lockdowns forced these in-person meet-ups to go virtual. …

Reshaping events in pharma Read More »

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

KNUTSFORD, United Kingdom — Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology [Image: From left, FIDE Directors Richard GB Langley, MD; Richard Warren, MD, PhD; Kenneth B Gordon, MD; Bruce E Strober, MD, PhD] November 10, 2021, UK. Fishawack Health, the leading commercialization partner …

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group Read More »

Transform patient experience with intelligent hyper-personalisation

Since 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and patient outreach, to prepare for the wave of digitisation in the healthcare industry. As part of these efforts, customer experience (CX) became a key focus area to ensure customer engagement and loyalty. Significant strides have been made …

Transform patient experience with intelligent hyper-personalisation Read More »

Deep Dive: Communications and Commercialisation

The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. In some cases it was an accelerant for existing plans, but it has also caused some new shifts in the landscape, shifts that have yet to be completed. This issue assesses European pharma’s approach to strategic …

Deep Dive: Communications and Commercialisation Read More »

Virtual engagement and collaborations: the pharmaphorum podcast

As the world passes the year and a half mark of the COVID-19 pandemic, the evolving ‘new normal’ experience across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals. Joining the pharmaphorum podcast to discuss these changes is Impetus Digital’s co-founder and CEO Natalie Yeadon, in a special episode sponsored …

Virtual engagement and collaborations: the pharmaphorum podcast Read More »

The post-COVID future of physician sample access and engagement

Building modern commercialisation strategies requires pharma to find the right balance of old ways and new approaches, says Cardinal Health’s Jennifer Baughman. COVID-19 has fundamentally changed much of our lives – from how we interact with people to how we work. For the pharma industry, the pandemic’s changes were both abrupt and industry-altering, requiring companies …

The post-COVID future of physician sample access and engagement Read More »

4 ways emerging pharma companies can harness marketing content

Rapid creation of compliant marketing content is increasingly important and there are ways emerging pharma companies can stay ahead of the game – despite having fewer resources than bigger firms. A new pharma marketing content ebook from Veeva looks at best practices for building a content foundation that can enable long-term growth. It explains how …

4 ways emerging pharma companies can harness marketing content Read More »

Experts discuss the field force’s customer-centric future

The ways in which HCPs prefer to engage with pharma has been changing for quite some time, and the digital transformation brought by COVID has dramatically accelerated that. In a recent pharmaphorum webinar, in partnership with Axtria, commercialisation experts from across the industry discussed how the right field force training and execution in combination with …

Experts discuss the field force’s customer-centric future Read More »

Key insights for a successful first-time product launch

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. But with the proper planning and an agile approach, they can be more successful than they realise, says Veeva’s Ian Hale. He takes us through the challenges of a successful launch and explains what pre-commercial …

Key insights for a successful first-time product launch Read More »

Designing HCP engagement for the next normal

Life sciences companies’ engagement with HCPs has changed significantly in the past 12 months, as the COVID-19 pandemic struck. Restrictions to in-person face-to-face interactions have resulted in increased use of remote and digital channels. Many life sciences companies have begun 2021 by reviewing how they respond to the longer-term impact of this change, and its …

Designing HCP engagement for the next normal Read More »

4 ways to embed data-driven best practice in pharma HCP communications

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Over the 12 months to December 2020 the number of global Veeva CRM Engage Meetings increased sixfold, while those held in Europe saw an eight-fold increase – with 200,000 remote …

4 ways to embed data-driven best practice in pharma HCP communications Read More »